Author/Authors :
Yousefichaijan, Parsa Department of Pediatric Nephrology - Amir Kabir Hospital - Arak University of Medical Sciences, Arak, Iran , Rezagholizamenjany, Masoud School of Medicine - Arak University of Medical Sciences, Arak, Iran , Kahbazi, Manijeh Department of Pediatric - Arak University of Medical Sciences, Arak, Iran , Rafiei, Mohamad Department of Biostatistics - Arak University of Medical Sciences, Arak, Iran , Taherahmadi, Hassan Department of Pediatric - Arak University of Medical Sciences, Arak, Iran , Kaviani, Parisa School of Medicine - Arak University of Medical Sciences, Arak, Iran , Arjmand, Ali Department of Biostatistics - Arak University of Medical Sciences, Arak, Iran
Abstract :
Background: Pyelonephritis as a life-threatening infection often leads to renal scarring, which presumably controls by minerals.
Objectives: The aim of this study was pyelonephritis treatment by vitamin A in children.
Methods: In the current study,106 cases from Imam Reza pediatric clinic and Amir-Kabir Hospital, considered a study group. Children
divided into groups with or without urinary incontinence. Demographic data, clinical manifestations, and urinary biomarkers
were evaluated and then statistically analyzed.
Results: Our data showed that there is a statistical difference between study groups in terms of dysuria (P = 0.001), abdominal pain
(P = 0.001), frequency (P = 0.003), incontinency (P = 0.001), urgency (P = 0.002), intermittency (P = 0.004) and fever (P = 0.002).
Conclusions: It has been assumedthat vitaminAas a therapeutic agent could be used in children with vesicoureteral reflux induced
by Pyelonephritis and congenital anomalies.
